Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Clinical Features and Possible Mechanisms in Patients With Sarcopenia in Parkinson's Disease

Authors not listed

Central South University · 2024

Abstract

Parkinson\'s Disease (PD) and sarcopenia are prevalent age-related syndromes, often occurring simultaneously within individuals. Sarcopenia is notably common among PD patients, with severe cases affecting approximately one in every five individuals with PD. Moreover, sarcopenia is closely linked to the accelerated progression of PD, diminished quality of life, heightened mortality risk, and increased susceptibility to falls and fractures. Therefore, early detection of sarcopenia assumes particular significance as it offers an opportunity for interventions aimed at mitigating or delaying muscle degeneration, potentially influencing PD outcomes. This review will delve into the relationship between sarcopenia and PD, methods for screening and testing sarcopenia, and potential avenues for further research and the development of strategies for risk reduction and treatment

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-25 MST

Cite this

APA
Anonymous. (2024). Clinical Features and Possible Mechanisms in Patients With Sarcopenia in Parkinson's Disease. <em>Central South University</em>. https://clinicaltrials.gov/study/NCT06511531
Vancouver
Anonymous. Clinical Features and Possible Mechanisms in Patients With Sarcopenia in Parkinson's Disease. Central South University. 2024.
BibTeX
@misc{anon2024Clinic, title = {Clinical Features and Possible Mechanisms in Patients With Sarcopenia in Parkinson's Disease}, author = {Anonymous}, journal = {Central South University}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings